| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | President &CEO
3 companies
Higgins John L serves as a Director at OABI and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 9 buys and 48 sells. Those positions are worth an estimated $27.7M at current prices.
Historically, Higgins John L's trades have earned a middling insider score of 66/100 across 18 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +8.8%.
The biggest single holding is LGND (~$27.7M) as Director. The recent filings there lean toward selling, a net 341,329 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2017 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sell | 2,258 | $140.34 | $316,887.72 | -1.6% | |
| Nov 16, 2017 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sell | 5,269 | $142.53 | $750,990.57 | -3.5% | |
| Sep 5, 2017 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 5,000 | $130.00 | $650,000.00 | -3.5% | |
| Aug 8, 2017 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 5,483 | $125.00 | $685,375.00 | -3.8% | |
| Jun 9, 2017 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 12,000 | $114.87 | $1,378,440.00 | -7.9% | |
| Mar 20, 2017 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sell | 4,000 | $109.10 | $436,400.00 | -2.8% | |
| Mar 8, 2017 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 4,000 | $107.06 | $428,240.00 | -3.0% | |
| Sep 22, 2016 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sell | 3,000 | $117.34 | $352,020.00 | -2.4% | |
| Sep 8, 2016 | TECH Bio-Techne Corp | Director | Sell | 1,700 | $109.83 | $186,715.93 | -55.6% | |
| Mar 7, 2016 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 10,833 | $102.47 | $1,110,027.20 | -8.3% |